|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/519 | (2006.01) |
| C07D 475/04 | (2013.01) | ||
| A61P 25/00 | (2006.01) | ||
| C07D 213/80 | (2013.01) | ||
| A61P 25/00 | (2018.01) | ||
| C07D 491/052 | (2006.01) | ||
| C07C 55/08 | (2013.01) | ||
| C07C 55/08 | (2006.01) | ||
| C07C 57/15 | (2006.01) | ||
| C07C 57/15 | (2013.01) | ||
| C07C 59/06 | (2006.01) | ||
| C07C 65/05 | (2013.01) | ||
| C07C 65/05 | (2006.01) | ||
| C07C 59/06 | (2013.01) | ||
| C07C 309/04 | (2006.01) | ||
| C07B2200/13 | (2013.01) | ||
| C07C 309/29 | (2006.01) | ||
| C07C 309/04 | (2013.01) | ||
| C07C 309/30 | (2006.01) | ||
| C07C 309/30 | (2013.01) | ||
| C07D 213/80 | (2006.01) | ||
| C07C 309/29 | (2013.01) | ||
| C07D 475/04 | (2006.01) | ||
| A61K 31/519 | (2013.01) |
| (11) | Number of the document | 3807279 |
| (13) | Kind of document | T |
| (96) | European patent application number | 19811127.0 |
| Date of filing the European patent application | 2019-05-30 | |
| (97) | Date of publication of the European application | 2021-04-21 |
| (45) | Date of publication and mention of the grant of the patent | 2025-12-31 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2019/034505 |
| Date | 2019-05-30 |
| (87) | Number | WO 2019/232120 |
| Date | 2019-12-05 |
| (30) | Number | Date | Country code |
| 201862678025 P | 2018-05-30 | US | |
| 201862726612 P | 2018-09-04 | US | |
| 201962822336 P | 2019-03-22 | US | |
| 201937661 | 2019-05-28 | GC |
| (72) |
LEVY, Daniel, E. , US
SMITH, Neil , US
REIS, Jonathan , US
YOSHINO, Hiroshi , JP
KOMODA, Taichi , JP
SHIRO, Yuichi , JP
MURATA, Shunichi , JP
MATSUMOTO, Takayoshi , JP
KISHIMOTO, Kaito , JP
|
| (73) |
PTC Therapeutics MP, Inc. ,
500 Warren Corporate Center Drive, Warren, NJ 07059,
US
|
| (54) | PHARMACEUTICALLY ACCEPTABLE SALTS OF SEPIAPTERIN WITH IMPROVED STABILITY |
| PHARMACEUTICALLY ACCEPTABLE SALTS OF SEPIAPTERIN WITH IMPROVED STABILITY |